Efficient generation of canine bone marrow-derived dendritic cells

Journal of Veterinary Medical Science

Volumn 68, Issue 8, 2006, Pages 809-814

  Isotani, Mayu ^a   Katsuma, Kensuke ^a   Tamura, Kyoichi ^a   Yamada, Misato ^a   Yagihara, Hiroko ^a   Azakami, Daigo ^a   Ono, Kenichiro ^b   Washizu, Tsukimi ^a   Bonkobara, Makoto ^a  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bone marrow; Canine; Dendritic cell; Generation

Indexed keywords

GLYCOPROTEIN P 15095; HLA ANTIGEN CLASS 2;

ANIMAL; ANIMAL DISEASE; ARTICLE; BONE MARROW CELL; CULTURE TECHNIQUE; CYTOLOGY; DENDRITIC CELL; DOG; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGENS, CD11C; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; DENDRITIC CELLS; DOGS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II;

CANIS FAMILIARIS; FELIDAE;

EID: 33748451071     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.68.809     Document Type: Article

References (27)

1. Ashley, D. M., Faiola, B., Nair, S., Hale, L. P., Bigner, D. D. and Gilboa, E. 1997. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J. Exp. Med. 186: 1177-1182.
2. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
3. Bonkobara, M., Zukas, P. K., Shikano, S., Nakamura, S., Cruz, P. D. Jr. and Ariizumi, K. 2001. Epidermal Langerhans cell-targeted gene expression by a dectin-2 promoter. J. Immunol. 167: 6893-6900.
4. Boussiotis, V. A., Freeman, G. J., Gray, G., Gribben, J. and Nadler, L. M. 1993. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J. Exp. Med. 178: 1753-1763.
5. Chang, G. C., Lan, H. C., Juang, S. H., Wu, Y. C., Lee, H. C., Hung, Y. M., Yang, H. Y., Whang-Peng, J. and Liu, K. J. 2005. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma. Cancer 103: 763-771.
6. +-derived dendritic cells following exposure to various expansion and maturational stimuli. Clin. Immunol. 98: 280-292.
7. Gyorffy, S., Rodriguez-Lecompte, J. C., Woods, J. P., Foley, R., Kruth, S., Liaw, P. C. and Gauldie, J. 2005. Bone marrow-derived dendritic cell vaccination of dogs with naturally occurring melanoma by using human gp100 antigen. J. Vet. Intern. Med. 19: 56-63.
8. + bone marrow progenitor cells. Transplantation 70: 1437-1442.
9. Ibisch, C., Pradal, G., Bach, J. M. and Lieubeau, B. 2005. Functional canine dendritic cells can be generated in vitro from peripheral blood mononuclear cells and contain a cytoplasmic ultrastructural marker. J. Immunol. Methods 298: 175-182.
10. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R. M. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
11. Ishikawa, A., Motohashi, S., Ishikawa, E., Fuchida, H., Higashino, K., Otsuji, M., Iizasa, T., Nakayama, T., Taniguchi, M. and Fujisawa, T. 2005. A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin. Cancer Res. 11: 1910-1917.
12. Labeur, M. S., Roters, B., Pers, B., Mehling, A., Luger, T. A., Schwarz, T. and Grabbe, S. 1999. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 162: 168-175.
13. Larsen, C. P., Ritchie, S. C., Hendrix, R., Linsley, P. S., Hathcock, K. S., Hodes, R. J., Lowry, R. P. and Pearson, T. C. 1994. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152: 5208-5219.
14. Murakami, T., Tokunaga, N., Waku, T., Gomi, S., Kagawa, S., Tanaka, N. and Fujiwara, T. 2004. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene. Clin. Cancer Res. 10: 3871-3880.
15. Palucka, K. A., Taquet, N., Sanchez-Chapuis, F. and Gluckman, J. C. 1998. Dendritic cells as the terminal stage of monocyte differentiation. J. Immunol. 160: 4587-4595.
16. Sallusto, F. and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179: 1109-1118.
17. Schlienger, K., Craighead, N., Lee, K. P., Levine, B. L. and June, C. H. 2000. Efficient priming of protein antigen-specific human CD4(+) T cells by monocyte-derived dendritic cells. Blood 96: 3490-3498.
18. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296.
19. Stift, A., Sachet, M., Yagubian, R., Bittermann, C., Dubsky, P., Brostjan, C., Pfragner, R., Niederle, B., Jakesz, R., Gnant, M. and Friedl, J. 2004. Dendritic cell vaccination in medullary thyroid carcinoma. Clin. Cancer Res. 10: 2944-2953.
20. + hematopoietic progenitor cells. Blood 87: 1292-1302.
21. + T-cell responses in patients with metastatic prostate cancer. J. Immunol. 174: 3798-3807.
22. Wahid, R., Cannon, M.J. and Chow, M. 2005. Dendritic cells and macrophages are productively infected by poliovirus. J. Virol. 79: 401-409.
23. Weber, M., Lange, C., Gunther, W., Franz, M., Kremmer, E. and Kolb, H. J. 2003. Minor histocompatibility antigens on canine hemopoietic progenitor cells. J. Immunol. 170: 5861-5868.
24. Weigel, B. J., Nath, N., Taylor, P. A., Panoskaltsis-Mortari, A., Chen, W., Krieg, A. M., Brasel, K. and Blazar, B. R. 2002. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses. Blood 100: 4169-4176.
25. + cell line (XS52) by IL-4, TNF-alpha, IL-1 beta, and agonistic anti-CD40 monoclonal antibody. J. Immunol. 163: 5331-5337.
26. + T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity. Int. J. Cancer 83: 532-540.
27. + dendritic cells. Proc. Natl. Acad. Sci. 93: 2588-2592.